| Decreased Survival With Maintenance Gefitinib Versus Placebo in Stage III NSCLC After Chemoradiotherapy and Consolidation | | May 28, 2008, 8:00 AM | J Clin Oncol | PubMed |
|
| Antiangiogenic Agents and Tumor Cavitation: Association With Squamous Histology but Not Hemoptysis in a Single-Institution Analysis | | May 8, 2008, 8:27 AM | J Thorac Oncol | PubMed |
|
| No Benefit With High-Dose Ifosfamide/Carboplatin/Etoposide in SCLC | | April 16, 2008, 8:34 AM | J Natl Cancer Inst | PubMed |
|
| Human Papillomavirus-Positive Head and Neck Cancer As a Distinct Disease Subtype Differences in Response to Treatment and Survival | | April 1, 2008, 8:23 AM | J Natl Cancer Inst | PubMed |
|
| Human Papillomavirus-Positive Head and Neck Cancer As a Distinct Disease Subtype Differences in Risk Factor Profiles | | April 1, 2008, 8:21 AM | J Natl Cancer Inst | PubMed |
|
| Correlation Between Promoter Methylation in Four Genes and Early Disease Recurrence in Stage I NSCLC | | April 1, 2008, 8:13 AM | N Engl J Med | PubMed |
|
| COX2 Inhibition in NSCLC: Improved Survival With Addition of Celecoxib to Gemcitabine/Carboplatin in COX2-Overexpressing Tumors | | February 27, 2008, 8:33 AM | J Clin Oncol | PubMed |
|
| Disease Control Rate at 8 Weeks as a Predictor of Survival in Advanced NSCLC | | February 1, 2008, 12:45 PM | J Clin Oncol | PubMed |
|
| Phase II Trial of Sunitinib in Pretreated, Metastatic NSCLC | | February 1, 2008, 12:44 PM | J Clin Oncol | PubMed |
|
| Increase in Proportion of HPV-Related Oral Squamous-Cell Carcinomas: Possible Role in Improved Survival Trends With Radiation Therapy | | February 1, 2008, 12:43 PM | J Clin Oncol | PubMed |
|
|
